TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: start of relapse
Endpoint domain: Adverse events/effects
Primary endpoint: Mean reduction in symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recovery time of clearance of lactic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase of at least 0.5mg/dl of the creatinine concentration 48h after the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Overall duration of erections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of erections
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of systemic hypotension
Endpoint domain: Adverse events/effects
Primary endpoint: mean wet night frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median change in IPSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression of antigen-stimulated chemokines (CCL3, CCL4, CCL2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Monocyte decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Functional result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive subscale score of the Alzheimer's Disease Assessment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Plasma Abeta42 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NIH Stroke Scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prevalence of aphasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Frequency of arterial hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CAT scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Major and clinically relevant non-major bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Levels of luteinizing hormone (LH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Levels of follicular stimulating hormone (FSH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cerebral oxygen saturation (ScO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Superior vena caval oxygen saturation (SvO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in neopterin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in lactulose and mannitol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elevation of myeloperoxidase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Registration for MyChart
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Logged into MyChart
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viewed clinical notes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression to full oral feeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rates of DV discussion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of DV disclosure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alive, HIV free, and nonstunted
Endpoint domain: Mortality/survival
Primary endpoint: Uterine quiescence in 6 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of ≥50% in uterine contractions in 6 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of days to delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median survival duration from reinduction
Endpoint domain: Mortality/survival
Primary endpoint: Median time to treatment failure (TTF) from reinduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tobacco susceptibility scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MACCE rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean value of ox‐LDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oxidation ratio of LDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of objective response sustained for at least 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in sitting systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Preference for neurostimulation treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Amount of bubbles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rates of side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Retinal white blood cell density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Patterns of non-nutritive sucking (NNS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breastfeeding duration
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time to task failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: jaw pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: jaw functional disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: corticomotor excitability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction of at least 50% in mania scales and 21-HAM-D
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score during ECV
Endpoint domain: Adverse events/effects
Primary endpoint: Stress level during ECV
Endpoint domain: Adverse events/effects
Primary endpoint: argyrophilic nucleolar organizer region count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: moderate and severe bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic accuracy of initial biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of immediate facial nerve dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Total costs of disposables
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: HGIN/ESCC at the resection site
Endpoint domain: Adverse events/effects
Primary endpoint: child diet quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative serum levels of troponin I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median time to meet escape criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in frequency of partial seizures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance with nicotinamide
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Therapeutic efficacy (non-response rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-limiting adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Mortality within four weeks
Endpoint domain: Mortality/survival
Primary endpoint: likelihood of future NSSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weight/shape concerns
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: glucose and insulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cost of intervention per caregiver
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Physician's global score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient's global score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: moderate-to-severe bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intracerebral haemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression to advanced prostatic cancer
Endpoint domain: Mortality/survival
Primary endpoint: transmyocardial ischaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: oxidative stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: myocyte damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Volume of gestational sac
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Safety and tolerability of pirfenidone
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Tmax of pirfenidone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean t1/2 of pirfenidone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative VAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of surgical anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical and urodynamical improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: radiographic assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum levels of IL-17A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum levels of IFN-β
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Myocardial perfusion defect scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: maximum wall dilation at peak systole
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: maximum wall dilation spatial gradients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean loss of enamel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for rescue dose of naloxone
Endpoint domain: Adverse events/effects
Primary endpoint: Time to respiratory rate of at least 10
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to Glasgow Coma Scale score of at least 13
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PCA hydromorphone usage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Economic abuse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical and/or sexual violence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional violence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: awareness of low-vision aids and practical strategies
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: percent change in CAR scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Benefits of omega-3 fatty acid addition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hyperactivity
Endpoint domain: Adverse events/effects
Primary endpoint: Distractibility
Endpoint domain: Adverse events/effects
Primary endpoint: Impulsivity
Endpoint domain: Adverse events/effects
Primary endpoint: FHNC (Urea synthesis capacity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Stent Thrombosis (ST)
Endpoint domain: Adverse events/effects
Primary endpoint: Recall of intervention elements
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Likelihood to seek help at a drug and alcohol centre
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: pain during injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of rehospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Mean number of hospital days spent in a psychiatric hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: mean pain VAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: responder rate for Patient's Global Assessment of Ankle Injury
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: incidence of dyspepsia
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of procedure-related major complications
Endpoint domain: Adverse events/effects
Primary endpoint: glottic narrowing with impaired ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: airway morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy of quadriceps exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with out-patient clinic services
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Trust in gynaecologists
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in numeric rating scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Headache Impact Test‐6 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate by 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse effects (rash)
Endpoint domain: Adverse events/effects
Primary endpoint: Abstinence from alcohol since discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abstinence at the sixth month following hospital discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initiation of treatment/self-help
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in scores on the Bipolar Depression Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in social and occupational functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: mean area of the PCV lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean filling time for vascular channels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean filling time for polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diarrhea longitudinal prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median duration of diarrhea episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of episodes with moderate or severe dehydration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curves for ifosfamide and metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total morphine equivalents required
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean negative affect scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidences of extreme craving peaks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients developing acute renal dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: No pain in the temporomandibular joint and/or anterior region of the neck
Endpoint domain: Adverse events/effects
Primary endpoint: Decrease in DMH where anterior HD ended
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in anterior HD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lipid metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adipose AMPK activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance to drugs included in drug challenge protocol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician Administered PTSD Scale (CAPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chemical pregnancy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Normal cycle of ovulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Increase of CD4 T cell counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Suppression of HIV viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Net renal clearance of levofloxacin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Bioavailability of ciprofloxacin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to peak concentrations of ciprofloxacin in sputum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accumulation index of fleroxacin in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accumulation index of fleroxacin in sputum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: activation-euphoria ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nocturnal core temperatures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean diurnal growth hormone concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Spherical aberration at 6 mm diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Desire to receive an SCP in the future
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Support for contact with the patient
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: number of mucin-depleted foci per colon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rerupture rate
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in SA colonization
Endpoint domain: Adverse events/effects
Primary endpoint: O-SSI post treatment difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Examination performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived helpfulness of peer contributions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sleep disturbance severity
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Overall Survival (OAS)
Endpoint domain: Mortality/survival
Primary endpoint: Mean end-of-trial tremor severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of cases with correct perceptions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of tremor reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sinus rhythm off antiarrhythmic medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intense nursing interventions initiated
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: decrease in screening intention
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Mean visual analog scale (VAS) for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient's grading of pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with pain medication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Amount of allogeneic red blood cells transfused
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic confidence in defining or excluding disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Marked or moderate enhancement of the upper gastrointestinal tract
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Relative energy intake during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Successful insertion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cholecystokinin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Minutes of waking per night
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Number of awakenings per night
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Errors on a choice reaction time task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning